You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc. (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .
Biologic Drugs cited in Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , ⤷  Try a Trial , and ⤷  Try a Trial .

Details for Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc. (D. Del. 2022)

Date Filed Document No. Description Snippet Link To Document
2022-03-18 1 1/09/2018 Novo Nordisk A/S 13 10,220,155 3/05/2019 Novo…following n Trademarks or BfPatents. ( Q the patent action involves 35 U.S.C. § 292.): DOCKET…PHARMACEUTICALS INC. PATENT OR DATE OF PATENT … □ Other Pleading PATENT OR DATE OF PATENT …INC. NOVO NORDISK A/S PATENT OR DATE OF PATENT External link to document
2022-12-21 61 Notice of Service U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed… 8 August 2022 1:22-cv-01040 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2023-03-22 85 ANDA Form U.S. Patent No. 9,687,611 expires on 2/27/2027; U.S. Patent Nos. 8,920,383, 9,775,953, 10,220,155, and…of Expiration of Patent: U.S. Patent No. 8,114,833 expires on 8/13/2025; U.S. Patent Nos. 8,684,969 and…expire on 1/20/2026; U.S. Patent No. 8,536,122 expires on 3/20/2026; Patent No. RE46,363 expires on 8/…expire on 7/17/2026; U.S. Patent No. 9,457,154 expires on 9/27/2027; U.S. Patent No. 9,132,239 expires on… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) External link to document
2023-03-22 86 Patent/Trademark Report to Commissioner of Patents 9,616,180; ;9,687,611; 9,775,953; 9,861,757; ;10,220,155; 10,335,462; 10,357,616; ;10,376,652; 11,097,… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833; 8,129,343… 8 August 2022 1:22-cv-01040 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.